ISRG
Intuitive Surgical Inc
$415.10
-12.20 (-2.86%)
At close · Jul 8
Market Cap
$147.01B
Shares
354,162,842
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-28 | — | |
| 8-K | 2026-05-04 | 2026-04-30 | |
| 10-Q | 2026-04-22 | 2026-03-31 | |
| 8-K | 2026-04-21 | — | |
| DEF 14A | 2026-03-13 | 2025-12-31 | |
| 8-K | 2026-03-02 | 2026-03-01 | |
| 10-K | 2026-02-03 | 2025-12-31 | |
| 8-K | 2026-01-22 | — | |
| 8-K | 2026-01-14 | — | |
| 8-K | 2025-12-18 | 2025-12-16 | |
| 10-Q | 2025-10-22 | 2025-09-30 | |
| 8-K | 2025-10-21 | — | |
| 10-Q | 2025-07-23 | 2025-06-30 | |
| 8-K | 2025-07-22 | — | |
| 8-K | 2025-05-15 | 2025-05-14 | |
| 8-K | 2025-05-05 | 2025-05-01 | |
| 10-Q | 2025-04-23 | 2025-03-31 | |
| 8-K | 2025-04-22 | — | |
| DEF 14A | 2025-03-14 | 2024-12-31 | |
| 10-K | 2025-01-31 | 2024-12-31 | |
| 8-K | 2025-01-23 | 2025-01-21 | |
| 8-K | 2025-01-15 | — | |
| 8-K | 2025-01-06 | 2025-01-01 | |
| 10-Q | 2024-10-18 | 2024-09-30 | |
| 8-K | 2024-10-17 | — | |
| 8-K | 2024-07-25 | 2024-07-24 | |
| 10-Q | 2024-07-19 | 2024-06-30 | |
| 8-K | 2024-07-18 | — | |
| 8-K | 2024-04-30 | 2024-04-25 | |
| 10-Q | 2024-04-19 | 2024-03-31 | |
| 8-K | 2024-04-18 | — | |
| 8-K | 2024-03-14 | — | |
| DEF 14A | 2024-03-08 | 2023-12-31 | |
| 10-K | 2024-01-31 | 2023-12-31 | |
| 8-K | 2024-01-23 | — | |
| 8-K | 2024-01-09 | — | |
| 8-K | 2023-10-31 | 2023-10-26 | |
| 10-Q | 2023-10-20 | 2023-09-30 | |
| 8-K | 2023-10-19 | — | |
| 10-Q | 2023-07-24 | 2023-06-30 | |
| 8-K | 2023-07-20 | — | |
| 8-K | 2023-05-16 | 2023-05-15 | |
| 8-K | 2023-05-02 | 2023-04-27 | |
| 10-Q | 2023-04-20 | 2023-03-31 | |
| 8-K | 2023-04-18 | — | |
| DEF 14A | 2023-03-10 | 0001-01-01 | |
| 10-K | 2023-02-10 | 2022-12-31 | |
| 8-K | 2023-01-24 | — | |
| 8-K | 2023-01-11 | — | |
| 8-K | 2022-10-25 | 2022-10-24 |
Showing 1–50 of 91 filings
Key facts
CIK
1035267
CUSIP
46120E602
13F (30d)
150 filings
87 filers
Visit website
Investor relations